Vähämurto Pauli, Silventoinen Kaija, Vento Seija I, Karjalainen-Lindsberg Marja-Liisa, Haapaniemi Aaro, Bäck Leif, Mannisto Susanna, Leppä Sirpa, Mäkitie Antti A
Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, P.O. Box 263, FI-00029 HUH, Helsinki, Finland.
Department of Oncology, Genome Scale Research Program, Helsinki University Hospital Cancer Center, University of Helsinki, Helsinki, Finland.
Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3839-3845. doi: 10.1007/s00405-016-3992-7. Epub 2016 Mar 24.
Sinonasally located lymphoid malignancies are rare lesions with first symptoms similar to other obstructive conditions. Additionally, they often coexist with nasal inflammation and mucosal necrosis. Therefore, time from the first symptoms to diagnosis tends to be long. Awareness and early diagnosis of this disease entity could improve treatment outcome. Altogether, 142 patients with sinonasal or nasopharyngeal (i.e. sinonasal tract, SNT) lymphoid malignancies, diagnosed and treated at the Helsinki University Hospital, during a 39-year period from 1975 to 2013, were retrospectively reviewed. There were 90 males (63 %) and 52 females (37 %) with a median age of 64 years (range 26-92). Eighty-four percent of the patients had primary diseases and 16 % had relapses of lymphoid malignancies primarily diagnosed at other locations. The mean duration of symptoms prior to diagnosis was 4.8 months (range 0.5-24). The most common histological entity was diffuse large B-cell lymphoma (43 %), followed by plasmacytoma (18 %). The most common location was nasopharynx (58 %) followed by nasal cavity (44 %) and paranasal sinuses (35 %). Sixty-nine percent of the lesions were at a single anatomic location of the sinonasal tract. Fifty-two percent of the cases were of Ann Arbor Stage I. Lymphoid malignancies form an important and diverse group in the differential diagnosis of SNT tumours. They most often present with general obstructive nasal symptoms due to tumour location. Most of them are primary lesions, highlighting the importance of an accurate diagnosis as early as possible.
鼻窦部位的淋巴恶性肿瘤是罕见病变,其首发症状与其他阻塞性疾病相似。此外,它们常与鼻炎症和黏膜坏死并存。因此,从首发症状到诊断的时间往往较长。对这种疾病实体的认识和早期诊断可改善治疗效果。我们回顾性分析了1975年至2013年期间在赫尔辛基大学医院诊断和治疗的142例鼻窦或鼻咽部(即鼻窦道,SNT)淋巴恶性肿瘤患者。其中男性90例(63%),女性52例(37%),中位年龄64岁(范围26 - 92岁)。84%的患者为原发性疾病,16%为主要在其他部位首次诊断的淋巴恶性肿瘤复发。诊断前症状的平均持续时间为4.8个月(范围0.5 - 24个月)。最常见的组织学类型是弥漫性大B细胞淋巴瘤(43%),其次是浆细胞瘤(18%)。最常见的发病部位是鼻咽部(58%),其次是鼻腔(44%)和鼻窦(35%)。69%的病变位于鼻窦道的单一解剖部位。52%的病例为Ann Arbor I期。淋巴恶性肿瘤在鼻窦道肿瘤的鉴别诊断中是一个重要且多样的组群。它们大多因肿瘤位置而出现一般性阻塞性鼻症状。大多数是原发性病变,凸显了尽早准确诊断的重要性。